(PRX) Prosus - Ratings and Ratios
Ecommerce, Classifieds, Payments, Food, Education, Etail, Fintech
Description: PRX Prosus
Prosus N.V. is a global leader in e-commerce and internet businesses, operating across multiple regions including Asia, Europe, Latin America, and North America. The company has a diverse portfolio of internet platforms, including classifieds, payments and fintech, food delivery, education technology, Etail, and ventures, as well as a significant stake in Tencent.
From a financial perspective, Prosus N.V. has a market capitalization of approximately €104.5 billion, indicating its substantial size and influence in the industry. The companys price-to-earnings (P/E) ratio is around 10.61, suggesting a relatively reasonable valuation compared to its earnings. Additionally, the forward P/E ratio is 12.17, indicating expected growth in earnings. The return on equity (RoE) is a notable 31.19%, demonstrating the companys ability to generate strong returns for its shareholders.
To further analyze Prosus N.V.s performance, key performance indicators (KPIs) such as revenue growth, gross merchandise value (GMV), and user acquisition costs can be examined. For instance, the companys GMV growth across its various platforms, such as food delivery and Etail, can provide insights into its operational performance. Moreover, metrics like customer lifetime value (CLV) and CLV-to-acquisition-cost ratio can help assess the companys ability to retain customers and drive long-term growth.
Considering the companys diversified portfolio and significant presence in the global e-commerce market, Prosus N.V.s financial performance is likely influenced by factors such as regional economic trends, competitive landscape, and technological advancements. As a Trading Analyst, it is essential to closely monitor these factors and assess their potential impact on the companys future performance.
PRX Stock Overview
| Market Cap in USD | 138,216m |
| Sub-Industry | Interactive Media & Services |
| IPO / Inception |
PRX Stock Ratings
| Growth Rating | 43.0% |
| Fundamental | 46.7% |
| Dividend Rating | 58.4% |
| Return 12m vs S&P 500 | 36.8% |
| Analyst Rating | - |
PRX Dividends
| Dividend Yield 12m | 0.64% |
| Yield on Cost 5y | 0.79% |
| Annual Growth 5y | 14.87% |
| Payout Consistency | 99.2% |
| Payout Ratio | 5.4% |
PRX Growth Ratios
| Growth Correlation 3m | 90.2% |
| Growth Correlation 12m | 82.5% |
| Growth Correlation 5y | 6.2% |
| CAGR 5y | 6.46% |
| CAGR/Max DD 5y | 0.10 |
| Sharpe Ratio 12m | 0.86 |
| Alpha | 44.42 |
| Beta | 0.671 |
| Volatility | 28.28% |
| Current Volume | 1415.4k |
| Average Volume 20d | 1687.5k |
| Stop Loss | 50.8 (-3.1%) |
| Signal | 0.42 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (14.05b TTM) > 0 and > 6% of Revenue (6% = 479.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -0.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 198.3% (prev 316.6%; Δ -118.3pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 1.33b <= Net Income 14.05b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.28b) change vs 12m ago -68.59% (target <= -2.0% for YES) |
| Gross Margin 38.20% (prev 29.82%; Δ 8.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.89% (prev 9.25%; Δ 2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.93 (EBITDA TTM -269.0m / Interest Expense TTM 549.0m) >= 6 (WARN >= 3) |
Altman Z'' 8.83
| (A) 0.22 = (Total Current Assets 22.08b - Total Current Liabilities 6.23b) / Total Assets 72.59b |
| (B) 1.09 = Retained Earnings (Balance) 79.33b / Total Assets 72.59b |
| warn (B) unusual magnitude: 1.09 — check mapping/units |
| (C) -0.01 = EBIT TTM -513.0m / Avg Total Assets 67.20b |
| (D) 3.70 = Book Value of Equity 79.33b / Total Liabilities 21.46b |
| Total Rating: 8.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.73
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 0.49% = 0.25 |
| 3. FCF Margin 9.12% = 2.28 |
| 4. Debt/Equity 0.32 = 2.45 |
| 5. Debt/Ebitda -60.50 = -2.50 |
| 6. ROIC - WACC -8.78% = -10.98 |
| 7. RoE 31.19% = 2.50 |
| 8. Rev. Trend 19.41% = 0.97 |
| 9. Rev. CAGR -0.40% = -0.07 |
| 10. EPS Trend 33.05% = 0.83 |
| 11. EPS CAGR 30.04% = 2.50 |
What is the price of PRX shares?
Over the past week, the price has changed by -0.38%, over one month by +2.46%, over three months by +14.79% and over the past year by +61.02%.
Is Prosus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRX is around 52.44 EUR . This means that PRX is currently overvalued and has a potential downside of 0.08%.
Is PRX a buy, sell or hold?
What are the forecasts/targets for the PRX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.6 | 11.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.2 | 11% |
PRX Fundamental Data Overview
Market Cap USD = 138.22b (118.66b EUR * 1.1648 EUR.USD)
CCE Cash And Equivalents = 7.11b USD (Cash only, last quarter)
P/E Trailing = 11.8869
P/E Forward = 13.7741
P/S = 19.2319
P/B = 2.7005
Beta = 0.683
Revenue TTM = 7.99b USD
EBIT TTM = -513.0m USD
EBITDA TTM = -269.0m USD
Long Term Debt = 14.92b USD (from longTermDebt, last quarter)
Short Term Debt = 1.35b USD (from shortLongTermDebt, last quarter)
Debt = 16.27b USD (Calculated: Short Term 1.35b + Long Term 14.92b)
Net Debt = 9.16b USD (from netDebt column, last quarter)
Enterprise Value = 147.38b USD (138.22b + Debt 16.27b - CCE 7.11b)
Interest Coverage Ratio = -0.93 (Ebit TTM -513.0m / Interest Expense TTM 549.0m)
FCF Yield = 0.49% (FCF TTM 729.0m / Enterprise Value 147.38b)
FCF Margin = 9.12% (FCF TTM 729.0m / Revenue TTM 7.99b)
Net Margin = 175.8% (Net Income TTM 14.05b / Revenue TTM 7.99b)
Gross Margin = 38.20% ((Revenue TTM 7.99b - Cost of Revenue TTM 4.94b) / Revenue TTM)
Tobins Q-Ratio = 1.86 (Enterprise Value 147.38b / Book Value Of Equity 79.33b)
Interest Expense / Debt = 3.37% (Interest Expense 549.0m / Debt 16.27b)
Taxrate = 2.45% (from quarterly Income Tax Expense: 82.0m / 3.35b)
NOPAT = -513.0m (EBIT -513.0m, no tax applied on loss)
Current Ratio = 3.54 (Total Current Assets 22.08b / Total Current Liabilities 6.23b)
Debt / Equity = 0.32 (Debt 16.27b / last Quarter total Stockholder Equity 51.05b)
Debt / EBITDA = -60.50 (Net Debt 9.16b / EBITDA -269.0m)
Debt / FCF = 22.33 (Debt 16.27b / FCF TTM 729.0m)
Total Stockholder Equity = 45.05b (last 4 quarters mean)
RoA = 19.36% (Net Income 14.05b, Total Assets 72.59b )
RoE = 31.19% (Net Income TTM 14.05b / Total Stockholder Equity 45.05b)
RoCE = -0.86% (Ebit -513.0m / (Equity 45.05b + L.T.Debt 14.92b))
RoIC = -0.84% (NOPAT -513.0m / Invested Capital 61.20b)
WACC = 7.94% (E(138.22b)/V(154.49b) * Re(8.49%)) + (D(16.27b)/V(154.49b) * Rd(3.37%) * (1-Tc(0.02)))
Shares Correlation 5-Years: -100.0 | Cagr: -19.98%
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 72.39% ; FCFE base≈828.6m ; Y1≈650.4m ; Y5≈425.1m
Fair Price DCF = 3.27 (DCF Value 7.33b / Shares Outstanding 2.24b; 5y FCF grow -25.66% → 3.0% )
Revenue Correlation: 19.41 | Revenue CAGR: -0.40%
Rev Growth-of-Growth: 111.5
EPS Correlation: 33.05 | EPS CAGR: 30.04%
EPS Growth-of-Growth: 121.6